Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action
about
Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effectsA physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortexDopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activityDifferential regulation of the postsynaptic clustering of γ-aminobutyric acid type A (GABAA) receptors by collybistin isoforms.SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CElectrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug's neuroprotective effectsEffects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons: a modeling study.Pharmacology of signaling induced by dopamine D(1)-like receptor activationSKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism.Renal dopamine receptors, oxidative stress, and hypertension.Membrane cholesterol modulates {beta}-amyloid-dependent tau cleavage by inducing changes in the membrane content and localization of N-methyl-D-aspartic acid receptorsSKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.Allosteric modulation of sigma-1 receptors elicits anti-seizure activitiesDeficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.G protein-coupled receptor kinases as regulators of dopamine receptor functions.Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation.The D₁ dopamine receptor agonist, SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells involving the extracellular signal-regulated kinase/p38 pathways.Gephyrin regulates GABAergic and glutamatergic synaptic transmission in hippocampal cell culturesActivation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.Role of Wnt/β-catenin pathway in the nucleus accumbens in long-term cocaine-induced neuroplasticity: a possible novel target for addiction treatment.The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease
P2860
Q21091199-F014B9CD-C7A3-4CBD-BD92-2D8B4D58E509Q24607115-CA260DD2-C8BA-419F-994F-D766BFC795A3Q26864383-7C436060-F593-41F5-B44B-39FCA0FFA2A5Q28295413-F5886BBD-28BA-4363-B9CB-6E2A59DDACABQ30155562-5B498236-9B7E-439E-B219-9063B7A2B26BQ30400003-4BB1F419-2B67-4EFA-835A-C7FCCEB2EDBBQ33721867-B4FE89E8-B396-4255-A11E-8AD2C7ACFB43Q33861896-8CB82627-93B5-4043-BD40-D18BB596DCC8Q34126949-4E982B5F-201B-45C4-A26C-E9B096937AC9Q34182064-F0A39370-475C-499D-BF25-9D164E1FCD22Q34367267-1562A200-56BE-4406-9539-917CB15CE5E8Q34489199-2FD8B302-CE53-4932-AE11-BEA137EC77BBQ35626923-953CB5D1-B184-4921-9322-F0399C81B846Q35978091-C76F0F16-7BC6-4E79-BD79-E71A7D89A7DEQ36072048-675366FE-268E-4532-AD7C-807FEA5D56F1Q37325666-F562FAF4-7017-48F0-8FDD-75FA5CB0165BQ38335806-6F4C1777-8505-4CF5-8ECA-C061DDC11268Q38834292-024F9AF3-622F-4DB1-AFC8-AF7CF460B414Q38868897-6DC5BCA7-6493-4D4E-A584-A5D889D13BD1Q39227370-2D5BB420-9259-4948-8BC8-E59004FB12F4Q42146712-88FC1E91-D733-49BC-A6A0-8962B6C1038CQ46118269-5CE147C1-9BF7-458B-832B-2832FFA056C7Q47380696-E6E776E0-100A-45CD-8AFF-F64B21EF7837Q58436305-597918D0-C9A5-4696-AD7B-473E7FB32FB2
P2860
Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action
description
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/02/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/02/01)
@nl
наукова стаття, опублікована в лютому 2008
@uk
مقالة علمية (نشرت في فبراير 2008)
@ar
name
Neuroprotective effects of aty ...... ependent anti-oxidative action
@ast
Neuroprotective effects of aty ...... ependent anti-oxidative action
@en
Neuroprotective effects of aty ...... ependent anti-oxidative action
@nl
type
label
Neuroprotective effects of aty ...... ependent anti-oxidative action
@ast
Neuroprotective effects of aty ...... ependent anti-oxidative action
@en
Neuroprotective effects of aty ...... ependent anti-oxidative action
@nl
prefLabel
Neuroprotective effects of aty ...... ependent anti-oxidative action
@ast
Neuroprotective effects of aty ...... ependent anti-oxidative action
@en
Neuroprotective effects of aty ...... ependent anti-oxidative action
@nl
P2093
P2860
P3181
P1476
Neuroprotective effects of aty ...... ependent anti-oxidative action
@en
P2093
Guo-Zhang Jin
Jing-Ru Wang
Pei-Hua Sun
Xuechu Zhen
Zhang-Jin Zhang
P2860
P304
P3181
P356
10.1111/J.1471-4159.2007.05062.X
P407
P577
2008-02-01T00:00:00Z